News

Inflectra is a chimeric human murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNF alpha but not to lymphotoxin a (TNF

BXQ-350 is a nanovesicle formulation of Saposin C (sphingolipid activator protein C) and the phospholipid dioleoylphosphatidylserine (DOPS). Earlier, the company secured a Phase II Bridge Award (Small Business

The company has reported that ONS-3010 met the primary endpoints in its first-in-human study, which was conducted by the Centre for Human Drug Research (CHDR) in Leiden, The

ZYAN1 is an orally bioavailable hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor being developed to increase the natural production of erythropoietin (EPO) as well as the efficacy of injectable EPO

The launch follows a decision from the US District Court for the District of New Jersey that US Patent No. 7,524,834 is invalid, and AstraZeneca’s request for a

The approval was based on data from a multicenter, randomized, double-blind, placebo-controlled Phase III SELECT trial. A total of 392 patients were included in the trial, in which

Erbitux is a highly active IgG1 monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Merck has already positioned Japan as its regional Research and Development hub

The company has submitted a new drug application (NDA) under the FDA’s fast track program and is based on results from the PARADIGM-HF trial, which is claimed to

Kerasal Complete Care brings together two highly effective treatments to restore healthy nail appearance and treat toe and foot skin fungus (athlete’s foot) in a convenient dual-pack. Moberg